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Background: The superiority of drug-eluting stents (DES) over bare-metal stents (BMS) 7 years after unprotected left main coronary artery (ULMCA) 
stenting is little known.
methods: From 2003 to 2005, 250 patients with coronary artery disease underwent ULMCA stenting (DES: 128, BMS: 122; acute coronary 
syndrome cases excluded). We compared the clinical outcomes, including cardiac death, non-fatal myocardial infarction (MI), and target lesion 
revascularization (TLR), between patients who received DES and BMS.
results: Median follow-up duration was 2623 days. The incidence of cardiac death or non-fatal MI at 7 years was similar between the 2 groups 
(DES, 9.2%; BMS, 11.9%; p = 0.59). The incidence of 7-year TLR was significantly lower in the DES group than in the BMS group (27.1% vs. 37.8%, 
p = 0.026); the incidence from 1 to 4 years and that beyond 4 years were similar between the 2 groups (Figure A). Among patients with bifurcation 
lesions, whereas the incidence of 7-year TLR was significantly lower in the DES group than the BMS group in patients undergoing single-stent 
procedures, it was similar between the 2 groups among patients undergoing two-stent procedures (Figure B).
conclusion: Hard outcomes, including cardiac death and MI, of patients undergoing ULMCA stenting for 7 years were favorable whether after DES 
or BMS implantation. The TLR rate after DES implantation, without using the two-stent procedure, was superior to that after BMS implantation when 
considering TLR during the late phase.
 
